Treating Obstructive Sleep Apnea: CPAP vs. Oral Appliance Therapy – Which Is Right for You?

Obstructive Sleep Apnea (OSA) affects millions of people, often times without them even knowing it. Approximately 30 million Americans are estimated to have OSA but only about 6 million are diagnosed. This means that a large number of people are undiagnosed. OSA is characterized by repeated interruptions in breathing during sleep. This can lead to…

Menopause and Sleep Disorders

Menopause is a significant phase in a woman’s life, marking the end of her reproductive cycle. It is often accompanied by a range of symptoms, both physical and emotional. One of the most common and troubling issues faced by women during menopause is sleep disorders. These disorders can severely impact the quality of life, making…

The FDA Approves the First Prescription Medication for OSA Patients with Obesity 

The FDA has approved the first medication useful in treating adults exhibiting moderate-to-severe OSA with obesity. Eli Lilly and Company announced the US Food and Drug Administration (FDA) approved Zepbound (tirzepatide) as the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. “Too often, OSA is brushed off as…